Moderator: Michael D. Daubs, MD
177. Chronicity of preoperative opioid usage predicts patient satisfaction, return to work, and achieving ODI MCID up to two years after lumbar fusion: analysis from the Michigan spine surgery improvement collaborative (MSSIC)
Hesham M. Zakaria, MD1; Michael S. Bazydlo, MS2; Lonni R. Schultz, PhD1; Jad G. Khalil, MD3; Jason M. Schwalb, MD4; Paul Park, MD5; Victor Chang, MD6
1Henry Ford Hospital, Detroit, MI, US; 2Henry Ford Health System, Detroit, MI, US; 3Michigan Orthopaedic Institute, Southfield, MI, US; 4Department of Neurological Surgery, University of Rochester, Rochester, NY, US; 5University Of Michigan – Dept. of Neurosurgery, Ann Arbor, MI, US; 6Henry Ford West Bloomfield Hospital, West Bloomfield, MI, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
178. Metastatic spine disease: should patients with short life expectancy be denied surgical care?
Nicolas Dea, MD, MSc, FRCSC1; Anne Versteeg, MD, MHS2; Arjun Sahgal, FRCP3; Joannes J. Verlaan, MD, PhD4; Raphaële Charest-Morin, MD5; Charles G. Fisher, MD, FRCSC, MHS6
1Blusson Spinal Cord Center, Vancouver, BC, Canada; 2Heidelberglaan 100, Utrecht, Netherlands; 3Toronto, ON, Canada; 4University Medical Center Utrecht, Utrecht, Netherlands; 5Quebec, QC, Canada; 6Vancouver General Hospital, Vancouver, BC, Canada
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
179. Predictors of clinical outcome following surgery for lumbar spinal stenosis: a study of postoperative pain and disability trajectories
Jeffrey Hebert, PhD, DC1; Erin Bigney, MA2; Niels Wedderkopp, MD, PhD3; Eden A. Richardson, BA2; Mariah A. Darling, BS2; Neil A. Manson, MD, FRCSC2
1Murdoch University, Perth, Australia; 2Canada East Spine Centre, Saint John, NB, Canada; 3Orthopaedic Department, Mddelfart, Denmark
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
180. Is outpatient anterior lumbar fusion (ALIF) safe? an analysis of 30-day outcomes
Jeremy A. Jones, MD1; Azeem T. Malik, MBBS2; Safdar N. Khan, MD2; Elizabeth Yu, MD2; Jeffery Kim, MD2
1Columbus, OH, US; 2The Ohio State University Wexner Medical Center, Columbus, OH, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
Discussion
181. Sequential changes in lumbar lordosis and segmental stability following lateral interbody cage placement, smith-peterson osteotomy, and anterior longitudinal ligament release
Richard Hurley Jr., MD1; Amy Claeson, PhD2; Jason A. Inzana, PhD3; Anup Gandhi, PhD2; Zachary Child, MD4
1Sacramento, CA, US; 2Zimmer Biomet, Westminster, CO, US; 3Boulder, CO, US; 4Tahoe Center for Orthopaedics, South Lake Tahoe, CA, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
182. Radiation exposure in posterior lumbar fusion: a comparison of CT image-guided navigation, robotic assistance and intraoperative fluoroscopy
Erik Wang, BA1; Jordan H. Manning, BA1; Christopher Varlotta, BS1; Dainn Woo, BS1; Ethan W. Ayres, MPH1; Max Egers, BS2; Edem J. Abotsi, BA1; Dennis Vasquez-Montes, MS, BA1; Themistocles S. Protopsaltis, MD1; Jeffrey A. Goldstein, MD, FACS1; Anthony K. Frempong-Boadu, MD3; Peter G. Passias, MD4; Aaron J. Buckland, MBBS, FRACS1
1Department of Orthopedic Surgery, NYU Langone Orthopedic Hospital, NYU Langone Health, New York, NY, US; 2New York, NY, US; 3NYU Medical Center Dept. of Neurosurgery, New York, NY, US; 4NY Spine Institute, NYU Langone Health, New York, NY, US
FDA Device/Drug Status: Brainlab Airo Mobile Intraoperative CT scanner (Approved for this indication)
183. Patient outcomes following short-segment lumbar fusion are not affected by PI-LL mismatch
Srikanth Divi, MD; Dhruv K. Goyal, BA1; Matthew S. Galetta, BA1; Taolin Fang, MD, PhD2; Kristen Nicholson, PhD3; D. Greg Anderson, MD3; Mark F. Kurd, MD4; Jeffrey A. Rihn, MD5; Ian D. Kaye, MD3; Barrett Woods, MD6; Kris E. Radcliff, MD7; Alan S. Hilibrand, MD3; Alexander R. Vaccaro, MD, PhD3; Christopher K. Kepler, MD, MBA1; Gregory D. Schroeder, MD2
1Philadephia, PA, US; 2Rothman Institute, Thomas Jefferson University, Philadelphia, PA, US; 3Rothman Institute, Philadelphia, PA, US; 4Rothman Institute, Bryn Mawr, PA, US; 5Thomas Jefferson University Hospital, The Rothman Institute, Philadelphia, PA, US; 6Egg Harbor Twp, NJ, US; 7Rothman Institute, Thomas Jefferson University, Egg Harbor Township, NJ, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
184. Comparison of standalone lateral lumbar interbody fusion and open laminectomy and posterolateral instrumented fusion in the treatment of adjacent segment disease following previous lumbar fusion surgery
Philip Louie, MD1; Brittany E. Haws, MD1; Jannat M. Khan, MD2; Jonathan Markowitz, BS3; Kamran Movassaghi4; Gregory Lopez, MD5; Howard S. An, MD6; Frank M. Phillips, MD2; Arash Sayari, BS, MD1
1Rush University Medical Center, Chicago, IL, US; 2Midwest Orthopaedics at Rush University, Chicago, IL, US; 3Rush Medical College, Chicago, IL, US; 4Glendale, CA, US; 5Rush University, Dept. Of Orthopaedics, Winfield, IL, US; 6Rush University Medical Center, Department of Orthopedic Surgery, Chicago, IL, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
185. Reoperation rates after single-level lumbar discectomy in the military health system
Donald R. Fredericks Jr., MD1; Donald F. Colantonio, MD1; Scott Wagner, MD1; Melvin D. Helgeson, MD2
1Walter Reed National Military Medical Center, Bethesda, MD, US; 2North Potomac, MD, US
FDA Device/Drug Status: This abstract does not discuss or include any applicable devices or drugs.
186. Cost-effectiveness of the Coflex interlaminar stabilization device: evidence for increasing physician reimbursement
Jared D. Ament, MD, MPH1; Amir A. Vokshoor, MD2
1Rancho Palos Verdes, CA, US; 2Institute of Neuro Innovation, Santa Monica, CA, US>
FDA Device/Drug Status: Coflex (Approved for this indication)
Discussion